Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Figure 8: Devices for endometriosis by product type and clinical development stage Despite the urgent need for diagnostics beyond laparoscopy, diagnostic research for endometriosis is relatively limited and mostly in early stages
We look forward to working with Ascendis to explore the potential of the TransCon technology platform to reduce the dosing frequency of GLP-1 receptor agonists and other treatments for cardiometabolic diseases. The TransCon tech is named after transient conjugation, which Ascendis describes as the companys unique ability to temporarily (transiently) link an inert carrier to a parent drug with known biology. The wide-ranging tech can help ensure drugs either act systemically throughout the body or locally
Zhang Z, Chen X, Lu P, Zhang J, Xu Y, He W, Li M, Zhang S, Jia J, Shao S, Xie J, Yang Y, Yu X
Guo EL, Katta R
US$ 29.15
US$ 25.55
US$ 23.70
US$ 21.54
